Welcome to our dedicated page for Sotera Health Co news (Ticker: SHC), a resource for investors and traders seeking the latest updates and insights on Sotera Health Co stock.
Sotera Health Co (SHC) delivers essential sterilization, lab testing, and advisory services ensuring safety across medical devices, pharmaceuticals, and food production. This page provides investors and industry professionals with timely updates on SHC's operational milestones, regulatory engagements, and strategic initiatives.
Access consolidated news on earnings reports, facility expansions, and technology innovations like gamma irradiation advancements. Track developments across SHC's Sterigenics, Nordion, and Nelson Labs divisions, including partnerships impacting global healthcare safety standards.
Bookmark this page for verified updates on SHC's compliance achievements, leadership changes, and industry contributions. Stay informed through carefully curated press releases and analysis-free reporting tailored for decision-makers in regulated industries.
Sotera Health reported positive financial results for the first quarter of 2024, with a 12.5% increase in net revenues to $248 million compared to the same period in 2023. Net income also saw a significant improvement, reaching $6 million or $0.02 per diluted share. Adjusted EBITDA increased by 13.7% to $112 million, and Adjusted EPS remained steady at $0.13. The company reaffirmed its 2024 outlook, anticipating continued growth and navigating market challenges.
FAQ
What is the current stock price of Sotera Health Co (SHC)?
What is the market cap of Sotera Health Co (SHC)?
